Provided by Tiger Fintech (Singapore) Pte. Ltd.

Guardant Health Inc.

63.49
+0.06000.09%
Volume:611.34K
Turnover:39.08M
Market Cap:7.92B
PE:-18.98
High:64.70
Open:63.46
Low:63.30
Close:63.43
52wk High:64.70
52wk Low:20.14
Shares:124.71M
Float Shares:119.55M
Volume Ratio:0.69
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3453
EPS(LYR):-3.5551
ROE:-4584.47%
ROA:-19.57%
PB:-25.92
PE(LYR):-17.86

Loading ...

Stock Track | Guardant Health Soars 5% as Piper Sandler Reaffirms Buy Rating

Stock Track
·
Aug 05

Guardant Health (GH) Receives a Buy from Piper Sandler

TIPRANKS
·
Aug 04

GH Research PLC Approves Key Resolutions at Annual Meeting

TIPRANKS
·
Aug 01

Stock Track | Guardant Health Plummets 10.25% Despite Strong Q2 Results and Raised Guidance

Stock Track
·
Aug 01

Guardant Health Inc. to Participate in Canaccord Genuity 45th Annual Growth Conference in Boston

Reuters
·
Aug 01

Guardant Health Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
Aug 01

Raymond James Reaffirms Their Buy Rating on Guardant Health (GH)

TIPRANKS
·
Aug 01

Guardant Health price target raised to $60 from $57 at Scotiabank

TIPRANKS
·
Jul 31

Stock Track | Guardant Health Plummets 5.29% Despite Strong Q2 Results and Analyst Upgrades

Stock Track
·
Jul 31

Guardant Health Inc : Leerink Partners Raises Target Price to $70 From $65

THOMSON REUTERS
·
Jul 31

Guardant Health Inc : Scotiabank Raises Target Price to $60 From $57

THOMSON REUTERS
·
Jul 31

Guardant Health Inc. Management Discusses Q2 2025 Financial Results in Conference Call

Reuters
·
Jul 31

Stock Track | Guardant Health Soars 5.66% After-Hours on Q2 Earnings Beat and Raised Guidance

Stock Track
·
Jul 31

Guardant Health Q2 Adjusted EPS USD -0.44 Vs. IBES Estimate USD -0.79

Reuters
·
Jul 31

Guardant Health Q2 Adj. EPS $(0.44) Beats $(0.79) Estimate, Sales $232.09M Beat $211.26M Estimate

Benzinga
·
Jul 31

Guardant Health Unveils Promising Results from RADIOHEAD Study, Highlighting Early Detection of Immunotherapy Response in Advanced Cancer Patients

Reuters
·
Jul 29

GH Research (GHRS) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
Jul 29

GH Research’s Strategic Path Forward: Overcoming Regulatory Hurdles and Capitalizing on Market Opportunities

TIPRANKS
·
Jul 24

TD Cowen Keeps Their Buy Rating on GH Research (GHRS)

TIPRANKS
·
Jul 24

GH Research Announces Global Pivotal Program Plans and Further Development Updates

GlobeNewswire
·
Jul 23